EUVIMEDScopri EUVIMED
Crossref

Xanthohumol Regulates Mitophagy in Osteosarcoma Cells via AMPK ‐ ULK1 ‐ FUNDC1 Signaling Pathway

Qiaofeng Ge, Zhiliang Yan, Qian Tian, Jiyan Zhang, Jia Li, Fang Cai, Long Zhang, Yonggang Zhu iD

Phytotherapy Research · 2025-05 · 39 (5) · 2393-2406

DOI: 10.1002/ptr.8468 ↗

At a glance

Journal article in Phytotherapy Research, published online on 2025-04-07. Written by Qiaofeng Ge and 7 co-authors. Institution: Department of Traumatic Orthopedics, Xi'an People's Hospital (Xi'an Fourth Hospital), Xi'an, Shanxi, China. Major MEDLINE topics: Mitophagy, Osteosarcoma, Flavonoids, Propiophenones. Cited 7 times so far (Crossref); 48 references. Funded by: The Research Incubation Fund of Xi'an People's Hospital, Zhejiang Province Medicine Science and Technology Project.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Osteosarcoma (OS) is the most common primary bone malignancy. The therapeutic efficacy for OS patients has remained stagnant in recent decades. Xanthohumol (XN), a flavonoid naturally found in hops, has demonstrated significant anticancer properties in lung and breast cancer. However, its effect on OS and the underlying molecular mechanisms remains uncertain. Therefore, the purpose of this study is to explore the relationship between XN and OS. Firstly, we assessed the impact of XN on OS cell proliferation and migration using CCK‐8, wound‐healing, transwell, and clonogenicity assays. Subsequently, we examined the effect of XN on mitophagy in OS cells through flow cytometry, immunofluorescence, transmission electron microscopy, and western blot analysis. Finally, we constructed siRNA targeting AMPK to validate the pathway. In vitro, we demonstrated that XN inhibited the proliferation and migration of OS cells in a concentration‐ and time‐dependent manner. Furthermore, XN induced mitochondrial damage in OS cells and increased reactive oxygen species (ROS) levels. RNA‐seq analysis suggested a potential mitophagy pathway, which we confirmed experimentally by showing that XN reduced ATP levels, altered mitochondrial membrane potential, and increased the expression of Atg5, Beclin‐1, and LC3 proteins. Interestingly, the mitophagy inhibitor Mdivi‐1 reversed the damage caused by XN to OS cells. Furthermore, we found that XN induced mitophagy and exerted anti‐OS effects through the activation of the AMPK‐ULK1‐FUNDC1 signaling pathway, which was effectively reversed after AMPK knockdown. In vivo, we demonstrated the therapeutic potential of XN using a subcutaneous OS nude mouse model without any organ toxicity. XN emerges as a promising pharmaceutical agent for targeting OS.

Subjects

MeSH terms (MEDLINE)

MitophagyOsteosarcomaFlavonoidsPropiophenonesAutophagy-Related Protein-1 HomologAMP-Activated Protein KinasesMembrane ProteinsMitochondrial ProteinsBone NeoplasmsIntracellular Signaling Peptides and ProteinsHumansSignal TransductionAnimalsCell Line, TumorCell ProliferationReactive Oxygen SpeciesCell MovementMiceMice, NudeMice, Inbred BALB CMembrane Potential, Mitochondrial

Author keywords

AMPK‐ULK1‐FUNDC1cell deathmitophagyosteosarcomaxanthohumol

Substances

xanthohumolFlavonoidsPropiophenonesAutophagy-Related Protein-1 HomologReactive Oxygen SpeciesAMP-Activated Protein KinasesULK1 protein, humanMembrane ProteinsMitochondrial ProteinsIntracellular Signaling Peptides and Proteins

Authors and institutions

  • Department of Traumatic Orthopedics, Xi'an People's Hospital (Xi'an Fourth Hospital), Xi'an, Shanxi, China.
  • Department of Cardiac Diseases, Xi'an People's Hospital (Xi'an Fourth Hospital), Xi'an, Shanxi, China.
  • Center for Rehabilitation Medicine, Department of Anesthesiology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China.
  • Department of Pain, Zhejiang Provincial People's Hospital, Affiliated People's Hospital of Hangzhou Medical College, Hangzhou, Zhejiang, China.

ORCID profiles: Yonggang Zhu

Funding

  • The Research Incubation Fund of Xi'an People's Hospital
  • Zhejiang Province Medicine Science and Technology Project

Cite

APA

Ge, Q., Yan, Z., Tian, Q., Zhang, J., Li, J., Cai, F., Zhang, L., & Zhu, Y. (2025). Xanthohumol Regulates Mitophagy in Osteosarcoma Cells via AMPK ‐ ULK1 ‐ FUNDC1 Signaling Pathway. Phytotherapy Research, 39(5), 2393-2406. https://doi.org/10.1002/ptr.8468

Vancouver

Ge Q, Yan Z, Tian Q, Zhang J, Li J, Cai F, et al. Xanthohumol Regulates Mitophagy in Osteosarcoma Cells via AMPK ‐ ULK1 ‐ FUNDC1 Signaling Pathway. Phytotherapy Research. 2025;39(5):2393-2406. doi:10.1002/ptr.8468

BibTeX
@article{Ge2025,
  author = {Ge, Qiaofeng and Yan, Zhiliang and Tian, Qian and Zhang, Jiyan and Li, Jia and Cai, Fang and Zhang, Long and Zhu, Yonggang},
  title = {Xanthohumol Regulates Mitophagy in Osteosarcoma Cells via AMPK ‐ ULK1 ‐ FUNDC1 Signaling Pathway},
  journal = {Phytotherapy Research},
  year = {2025},
  volume = {39},
  number = {5},
  pages = {2393--2406},
  doi = {10.1002/ptr.8468}
}
Start for free →